1. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: An analysis from the hellas-fh. (August 2022) Authors: Anagnostis, P.G.; Rizos, C.; Skoumas, I.; Rallidis, L.; Tziomalos, K.; Skalidis, E.; Kotsis, V.; Doumas, M.; Kolovou, G.; Sfikas, G.; Garoufi, A.; Lambadiari, V.; Dima, I.; Kiouri, E.; Agapakis, D.; Zacharis, E.; Antza, C.; Kolovou, V.; Koumaras, C.; Bantouvakis, G. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of TG/HDL-C and TYG indices with the prevalence of atherosclerotic cardiovascular disease in adult patients with familial hypercholesterolemia. (August 2022) Authors: Rizos, C.; Liamis, G.; Skoumas, I.; Garoufi, A.; Rallidis, L.; Tziomalos, K.; Kolovou, G.; Skalidis, E.; Kotsis, V.; Doumas, M.; Lambadiari, V.; Anagnostis, P.G.; Sfikas, G.; Dima, I.; Kiouri, E.; Polychronopoulos, G.; Kolovou, V.; Zacharis, E.; Antza, C.; Koumaras, C. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cholesterol levels of high-density lipoprotein (HDL-C), APOB/APOA1 ratio and cardiovascular risk in patients with familial hypercholesterolemia (FH): Data from the HELLAS-FH registry. (December 2020) Authors: Rizos, C.; Liamis, G.; Skoumas, I.; Rallidis, L.; Tziomalos, K.; Skalides, E.; Kotsis, V.; Garoufi, A.; Athyros, V.G.; Kolovou, G.; Sfikas, G.; Bilianou, E.; Koutagiar, I.; Kiouri, E.; Agapakis, D.; Zacharis, E.; Antza, C.; Attilakos, A.; Katsiki, N.; Koumaras, C. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical characteristics of patients with familial hypercholesterolemia: Data from the HELLAS-FH registry. (December 2020) Authors: Rizos, C.; Liamis, G.; Skoumas, I.; Rallidis, L.; Tziomalos, K.; Skalides, E.; Kotsis, V.; Garoufi, A.; Athyros, V.G.; Kolovou, G.; Sfikas, G.; Bilianou, E.; Koutagiar, I.; Kiouri, E.; Agapakis, D.; Zacharis, E.; Antza, C.; Attilakos, A.; Katsiki, N.; Anagnostis, P. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of high and low dose of rosuvastatin on fatty liver disease and adipokines in patients with nonalcoholic fatty liver disease. (December 2020) Authors: Boutari, C.; Tziomalos, K.; Pappas, P.; Sfikas, G.; Koumaras, C.; Doumas, M.; Athyros, V.G.; Karagiannis, A. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prevalence of non-coronary heart disease in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH. (August 2021) Authors: Anagnostis, P.; Rizos, C.; Skoumas, I.; Rallidis, L.; Tziomalos, K.; Skalides, E.; Kotsis, V.; Doumas, M.; Kolovou, G.; Sfikas, G.; Bilianou, E.; Koutagiar, I.; Kiouri, E.; Agapakis, D.; Zacharis, E.; Antza, C.; Koumaras, C.; Boutari, C.; Liamis, G.; Liberopoulos, E.N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗